We are Sorry, This Page doesn't Exist
Amgen Tops Forecasters on 2nd-Quarter Earnings
The US drug major reports lower sales and a sharp decline in operating cash flow, howeverRelated Stocks: AMGN,.....»»
Pfizer: Anticipated Growth at a Fair Value
The drug giant beat earnings expectations and raised guidance following strong Covid-related upsideRelated Stocks: PFE, BNTX,.....»»
Eli Lilly Rated Top in Innovation, Bristol-Myers Leader in Invention
IDEA Pharma rates drug companies in both categoriesRelated Stocks: LLY, BMY, RHHBY, AMGN, TEVA, REGN, SEGN, INCY, GSK, SNY, AZN,.....»»
The Week Ahead In Biotech (March 28-April 3): Acadia"s Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broad.....»»
Akebia Shares Climb on Positive Anemia Drug Study Results
Company hits 52-week high of $12.25Related Stocks: AKBA, AMGN, FGEN, GSK, OTSKY, MTZPY,.....»»
Wall Street jumps on coronavirus drug hopes; Fed in focus
U.S. stocks jumped to seven-week highs on Wednesday as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted the so-called market-leading FAANG stocks......»»
Wall Street jumps on coronavirus drug hopes; Fed decision awaited
U.S. stocks jumped to seven-week highs on Wednesday as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted shares of other technology and internet giants......»»
Shares gain after encouraging COVID-19 drug data, oil jumps
A gauge of global stocks climbed on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices surged......»»
Wall Street jumps on hopes of potential coronavirus drug
U.S. stocks opened higher on Wednesday after Gilead Sciences gave an encouraging update on a potential COVID-19 treatment, while upbeat earnings reports from Boeing and Google-parent Alphabet added to the sentiment......»»
Bayer and Teva Double Down on Worst M&A Deals of Decade
The companies both hit the dubious roster twice, but are joined by many of the biggest names in the drug industryRelated Stocks: BAYN, TEVA, GILD, MRK, NVS, BMY, PFE, GSK, SHRS, SNY, AMGN, A,.....»»
BeiGene Shares Climb Nearly 50% After Amgen Deal
Beijing-based company is first to gain FDA approval for a drug discovered by a Chinese companyRelated Stocks: BGNE, AMGN, ABBV, JNJ,.....»»
AbbVie’s Humira on Pace to Become Biggest Seller by 2024
Immunology drug scheduled to supplant the widely used heart medication Lipitor, tallying cumulative sales of $240 billionRelated Stocks: ABBV, AMGN, JNJ, PFE, BMY, TEVA, RHHBF, SHSE:600196,.....»»
Everything Jim Cramer said on "Mad Money," including Biogen drug, Hasbro and Logitech, Beyond Meat
CNBC's Jim Cramer says Biogen is one example why investors should buy individual stocks. He chats with the CEOs of Hasbro and Logitech after their earnings reports and breaks down why more downside may be in store for Beyond Meat......»»
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Biotech stocks saw some strength last week. Positive clinical readouts, a couple of M&A deals and hopes of drug companies clinching a broader opioid settlement agreement worked in favor of the sector. read more.....»»
PreMarket Prep Recap: Stormy Outlook For Cloud Stocks, Opioid Makers Rally On Settlement Talks
On Wednesday's PreMarket Prep show, earnings reports and ratings changes took a backseat to the negative news for cloud stocks and the positive news for opioid-associated drug distributors. read more.....»»
Everything Jim Cramer said on "Mad Money," including investing next week, foreign drug stocks
Jim Cramer breaks down the Trump administration's consideration to stop U.S. investing in Chinese businesses, recommends foreign pharmaceutical companies, reviews Conagra's earnings report and interview GoodRx CEO Doug Hirsch......»»
International Biotechnology Trust Plc Buys Biogen Inc, Amgen Inc, Insmed Inc, Sells Celgene ...
Related Stocks: AMGN, BIIB, INSM, VRTX, NBIX, EXEL, ARQL, IOVA, QURE, RGEN,.....»»
The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1) read more.....»»
Amgen Drug Breaks New Ground
Although still in early testing, the company's therapy could be a game changer for patients and investorsRelated Stocks: AMGN, MRTX, MRK, LLY,.....»»